Literature DB >> 6602089

Stimulation of cytotoxic T cells by liposomes containing influenza virus or its components.

C J Hackett, P M Taylor, B A Askonas.   

Abstract

Since inactivated virus preparations are poor inducers of influenza-specific cytotoxic T cells (Tc), studies were undertaken utilizing artificial vesicles (liposomes) as a means of delivering viral and H-2 antigens in a multivalent form and oriented with respect to a lipid bilayer. Liposomes prepared from extracted mouse cell lipids efficiently incorporated influenza-viral proteins and were not toxic in culture. Using polybrene to promote greater contact of liposomes with cells, liposomes prepared from whole virus could effectively stimulate memory Tc from spleens of intranasally infected mice in vitro. H-2 was not required in the liposomes to obtain stimulation, and its presence did not improve responses, which were always lower than in parallel stimulations using virally infected syngeneic cells. Liposomes prepared from purified influenza virion subunits (haemagglutinin, neuraminidase, matrix protein) were only slightly stimulatory in vitro, and were unable to prime mice for significant Tc memory.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602089      PMCID: PMC1454211     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  Isolation and N-terminal amino acid sequence of membrane-bound human HLA-A and HLA-B antigens.

Authors:  J Bridgen; D Snary; M J Crumpton
Journal:  Nature       Date:  1976-05-20       Impact factor: 49.962

3.  Cytotoxic T lymphocytes induced in mice by inactivated influenza virus vaccine.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.

Authors:  T J Braciale
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

5.  Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity.

Authors:  H J Zweerink; B A Askonas; D Millican; S A Courtneidge; J J Skehel
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

6.  Fluorescent monitoring of SDS gel electrophoresis.

Authors:  D N Talbot; D A Yphantis
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

7.  Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.

Authors:  A J McMichael; B A Askonas
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

8.  Formation of virosomes from influenza subunits and liposomes.

Authors:  J D Almeida; D C Edwards; C M Brand; T D Heath
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

9.  Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.

Authors:  T J Braciale; K L Yap
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  2 in total

1.  Isolation and studies of myxovirus glycoproteins.

Authors:  V A Berezin; V M Zaides; A F Artamonov; E S Isaeva; V M Zhdanov
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

2.  A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.

Authors:  E Watari; B Dietzschold; G Szokan; E Heber-Katz
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.